Aurora Cannabis (ACB) Non-Current Debt (2018 - 2025)
Aurora Cannabis (ACB) reported Non-Current Debt of $28.0 million for Q1 2025, down 18.14% year-over-year from $34.2 million in Q1 2024, and down 31.72% quarter-over-quarter from $41.0 million in Q4 2024.
Aurora Cannabis (ACB) Non-Current Debt (2018 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has 8 years of Non-Current Debt data on file, last reported at $28.0 million in Q1 2025.
- Non-Current Debt for Q1 2025 came in at $28.0 million, down 18.14% year-over-year; the trailing twelve-month figure through Mar 2025 was $28.0 million (down 18.14% YoY), and the FY2025 annual result was $28.0 million, down 18.14% from the prior year.
- Non-Current Debt eased to $28.0 million in Q1 2025 per ACB's latest filing, from $41.0 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $41.0 million in Q4 2024 and troughed at $29233.7 in Q1 2021.
- A 5-year average of $23.4 million and a median of $34.2 million in 2024 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2021 and 2022: Non-Current Debt tumbled 99.99% in 2021, then surged 41540.16% in 2022.
- A 5-year view of Non-Current Debt shows it stood at $94407.0 in 2021, then soared by 38896.32% to $36.8 million in 2022, then gained by 9.88% to $40.5 million in 2023, then gained by 1.41% to $41.0 million in 2024, then tumbled by 31.72% to $28.0 million in 2025.
- Business Quant data shows ACB's Non-Current Debt at $28.0 million in Q1 2025, $41.0 million in Q4 2024, and $39.6 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 569.60 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 28.01 Mn |
| Mar 31, 2025 | 28.01 Mn |
| Dec 31, 2024 | 41.02 Mn |
| Dec 31, 2024 | 41.02 Mn |
| Sep 30, 2024 | 39.62 Mn |
| Sep 30, 2024 | 39.62 Mn |
| Jun 30, 2024 | 37.25 Mn |
| Jun 30, 2024 | 37.25 Mn |
| Mar 31, 2024 | 34.22 Mn |
| Mar 31, 2024 | 34.22 Mn |
| Dec 31, 2023 | 40.45 Mn |
| Dec 31, 2023 | 40.45 Mn |
| Sep 30, 2023 | 37.96 Mn |
| Sep 30, 2023 | 37.96 Mn |
| Jun 30, 2023 | 37.39 Mn |
| Jun 30, 2023 | 37.39 Mn |
| Mar 31, 2023 | 26.75 Mn |
| Mar 31, 2023 | 26.75 Mn |
| Dec 31, 2022 | 36.82 Mn |
| Dec 31, 2022 | 36.82 Mn |